BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 16570681)

  • 1. HFE, hepcidin and ferroportin gene mutations are not present in Indian patients with primary haemochromatosis.
    Shukla P; Julka S; Bhatia E; Shah S; Nagral A; Aggarwal R
    Natl Med J India; 2006; 19(1):20-3. PubMed ID: 16570681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.
    Merryweather-Clarke AT; Cadet E; Bomford A; Capron D; Viprakasit V; Miller A; McHugh PJ; Chapman RW; Pointon JJ; Wimhurst VL; Livesey KJ; Tanphaichitr V; Rochette J; Robson KJ
    Hum Mol Genet; 2003 Sep; 12(17):2241-7. PubMed ID: 12915468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective release of Hepcidin not defective synthesis is the primary pathogenic mechanism in HFE-Haemochromatosis.
    Arnold J; Sangwaiya A; Bhatkal B; Arnold A
    Med Hypotheses; 2008; 70(6):1197-200. PubMed ID: 18054440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.
    Bridle KR; Frazer DM; Wilkins SJ; Dixon JL; Purdie DM; Crawford DH; Subramaniam VN; Powell LW; Anderson GJ; Ramm GA
    Lancet; 2003 Feb; 361(9358):669-73. PubMed ID: 12606179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis.
    Roetto A; Camaschella C
    Best Pract Res Clin Haematol; 2005 Jun; 18(2):235-50. PubMed ID: 15737887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: the genetic basis of haemochromatosis.
    Griffiths WJ
    Aliment Pharmacol Ther; 2007 Aug; 26(3):331-42. PubMed ID: 17635368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients.
    Santos PC; Cançado RD; Pereira AC; Schettert IT; Soares RA; Pagliusi RA; Hirata RD; Hirata MH; Teixeira AC; Figueiredo MS; Chiattone CS; Krieger JE; Guerra-Shinohara EM
    Blood Cells Mol Dis; 2011 Apr; 46(4):302-7. PubMed ID: 21411349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-HFE haemochromatosis.
    Wallace DF; Subramaniam VN
    World J Gastroenterol; 2007 Sep; 13(35):4690-8. PubMed ID: 17729390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload.
    Biasiotto G; Belloli S; Ruggeri G; Zanella I; Gerardi G; Corrado M; Gobbi E; Albertini A; Arosio P
    Clin Chem; 2003 Dec; 49(12):1981-8. PubMed ID: 14633868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of HFE and non-HFE gene mutations in Brazilian patients with hemochromatosis.
    Bittencourt PL; Marin ML; Couto CA; Cançado EL; Carrilho FJ; Goldberg AC
    Clinics (Sao Paulo); 2009; 64(9):837-41. PubMed ID: 19759876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-HFE hemochromatosis.
    Pietrangelo A
    Semin Liver Dis; 2005 Nov; 25(4):450-60. PubMed ID: 16315138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical expression of C282Y homozygous HFE haemochromatosis at 14 years of age.
    Rossi E; Wallace DF; Subramaniam VN; St Pierre TG; Mews C; Jeffrey GP
    Ann Clin Biochem; 2006 May; 43(Pt 3):233-6. PubMed ID: 16704763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemochromatosis: genetics and pathophysiology.
    Beutler E
    Annu Rev Med; 2006; 57():331-47. PubMed ID: 16409153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hereditary haemochromatosis: novel genes, novel diseases and hepcidin].
    Bergmans JP; Kemna EH; Janssen MC; Jacobs EM; Stalenhoef AF; Marx JJ; Swinkels DW
    Ned Tijdschr Geneeskd; 2007 May; 151(20):1121-7. PubMed ID: 17557668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele.
    Biasiotto G; Roetto A; Daraio F; Polotti A; Gerardi GM; Girelli D; Cremonesi L; Arosio P; Camaschella C
    Blood Cells Mol Dis; 2004; 33(3):338-43. PubMed ID: 15528154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-HFE-related hereditary iron overload].
    Aguilar-Martinez P
    Presse Med; 2007 Sep; 36(9 Pt 2):1279-91. PubMed ID: 17540536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in HAMP and HJV genes and their impact on expression of clinical hemochromatosis in a cohort of 100 Spanish patients homozygous for the C282Y mutation of HFE gene.
    Altès A; Bach V; Ruiz A; Esteve A; Felez J; Remacha AF; Sardà MP; Baiget M
    Ann Hematol; 2009 Oct; 88(10):951-5. PubMed ID: 19214511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the SLC40A1 gene modify HFE-related haemochromatosis phenotypes?
    Altès A; Bach V; Ruiz A; Esteve A; Remacha AF; Sardà MP; Felez J; Baiget M
    Ann Hematol; 2009 Apr; 88(4):341-5. PubMed ID: 18820912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].
    Himmelmann A; Bortoluzzi L; Jansen S; Fehr J
    Schweiz Med Wochenschr; 2000 Aug; 130(31-32):1112-9. PubMed ID: 11008304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic haemochromatosis: genes and mutations associated with iron loading.
    Camaschella C; Roetto A; De Gobbi M
    Best Pract Res Clin Haematol; 2002 Jun; 15(2):261-76. PubMed ID: 12401307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.